CLINICAL_TRIALS trial_result · 2009-10-23

Clinical Trial Update: Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderate to Severe Crohn's Disease (ACCESS) [Phase 3]

Phase 3 ACCESS trial of adalimumab in Canadian patients with moderate to severe Crohn's disease has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Abbott | Conditions: Crohn's Disease | Phase 3 | Status: COMPLETED | Results posted: 2009-10-23